从非小细胞肺癌的现实世界数据中确定治疗线
Connor B Grady1, Wei-Ting Hwang1, Joshua E Reuss2
1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Pharmacoepidemiology and drug safety
|November 25, 2024
概括
在转移性非小细胞肺癌 (mNSCLC) 中确定治疗线 (LOT) 的新规则包括向疗法. 这些更新的LOT规则改善了对mNSCLC治疗模式的现实数据分析.
科学领域:
- 在瘤学瘤学.
- 现实世界的数据分析分析.
- 临床试验方法论 临床试验方法论
背景情况:
- 准确确定治疗线 (LOT) 对于临床决策和转移性非小细胞肺癌 (mNSCLC) 的研究至关重要.
- 现有的LOT确定方法不能充分考虑在mNSCLC治疗中越来越多地使用向疗法.
- 需要更新的LOT规则,反映当前mNSCLC治疗范式.
研究的目的:
- 提出和验证新的规则,用于从mNSCLC患者的现实数据中确定LOT,特别是针对针对性治疗的整合.
- 为LOT确定建立一个标准化的框架,以加强在mNSCLC中对现实世界的证据的分析.
主要方法:
- 通过专家共识开发了LOT规则,使用来自ATOMIC驱动器突变注册表的550名ALK+或ROS1+mNSCLC患者的真实世界队列.
- 根据专家评价改进了LOT规则,并将其应用于EGFR+mNSCLC患者的独立队列.
- 利用电子医疗记录数据进行全面的LOT确定.
主要成果:
- 制定了六项新的LOT规则.
- 对1133名EGFR+mNSCLC患者的应用显示了2834个总LOT (每名患者中位数为2).
- 新规则在5.7%的LOT分配中与以前的方法不同,主要涉及有针对性的疗法,并确定了11%的治疗方案变化没有推进LOT.
结论:
- 开发的规则为使用现实数据评估mNSCLC治疗模式提供了一个更新的框架.
- 这些规则有效地纳入了针对性疗法在mNSCLC管理中日益增长的作用.
- 拟议的方法促进了从现实数据中确定LOT的标准化,这对于临床研究和决策至关重要.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.5K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.8K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K